Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 12/20 | 0.56 |
| ▸ | HSPB1 | P04792 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30584582 | 1.00 | PIN1 (0.56) | PIN1HSPB1ALDH1A1S1PR4MEN1 | |
| SCHEMBL30584631 | 0.85 | PIN1 (0.60) | PIN1ALDH1A1MEN1KMT2AGAA | |
| SCHEMBL1707043 | 0.79 | PIN1 (0.58) | PIN1HSPB1MEN1KMT2AMAPT | |
| SCHEMBL24392929 | 0.78 | PIN1 (0.43) | PIN1ALDH1A1MEN1KMT2AGAA | |
| SCHEMBL30584579 | 0.78 | PIN1 (0.43) | PIN1ALDH1A1MEN1KMT2AGAA | |
| SCHEMBL1706682 | 0.77 | PIN1 (0.59) | PIN1ALDH1A1KMT2AGAAMAPT | |
| SCHEMBL30584583 | 0.75 | ALDH1A1 (0.43) | PIN1ALDH1A1MEN1KMT2AHIF1A | |
| SCHEMBL29250710 | 0.75 | ALDH1A1 (0.43) | PIN1ALDH1A1MEN1KMT2AHIF1A | |
| SCHEMBL20500742 | 0.75 | PIN1 (0.42) | PIN1HSPB1 | |
| SCHEMBL3332690 | 0.74 | PIN1 (0.66) | PIN1ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116685583-A | Pyrimidine compounds, compositions and pharmaceutical uses thereof | 缆图药品公司 | 2023-09-01 | — | — | CN | disclosed |